Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide
Giuseppe Di Lorenzo(Saint Camillus International University of Health and Medical Sciences), Carlo Buonerba(CTO Andrea Alesini), Vincenzo Caputo(University of Naples Federico II), Rocco Morra(Federico II University Hospital), Pietro De Placido(University of Naples Federico II), Nicola Longo(University of Naples Federico II), Zahrasadat Navaeiseddighi(University of Florida), Simona Iaccarino(University of Naples Federico II), Felice Crocetto(University of Naples Federico II), Antonio Verde(University of Naples Federico II), Silvia Zappavigna(University of Campania "Luigi Vanvitelli"), Franco Morelli(Casa Sollievo della Sofferenza), Antonella Lucia Marretta(University of Naples Federico II), Mario Giuliano(Regione Campania), Livia Onofrio(University of Naples Federico II), Martina Viggiani(Fribourg Development Agency), Gaetano Facchini(Istituto Nazionale di Fisica Nucleare, Sezione di Napoli), Giuseppe Celentano(University of Naples Federico II), Ferdinando Costabile(University of Naples Federico II), Michele Caraglia(University of Campania "Luigi Vanvitelli"), Dario Bruzzese(University of Naples Federico II), Sabino De Placido, Marianna Abate(University of Campania "Luigi Vanvitelli"), Luca Scafuri(CTO Andrea Alesini), Erica Pietroluongo(University of Naples Federico II), Dario Ribera(University of Naples Federico II), Matteo Ferro(European Institute of Oncology), Alessandro Palmieri(University of Naples Federico II), Amalia Luce(University of Campania "Luigi Vanvitelli")
Cited by 23
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
|Journal of Clinical Oncology|2007|413
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
|Cancer Treatment Reviews|2018|282
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2013|273